Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
60,715,449
-
Shares change
-
+18,711,332
-
Total reported value, excl. options
-
$103,532,553
-
Value change
-
+$24,167,009
-
Put/Call ratio
-
83%
-
Number of buys
-
93
-
Number of sells
-
-68
-
Price
-
$1.70
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q1 2025
206 filings reported holding HUMA - Humacyte, Inc. - COM as of Q1 2025.
Humacyte, Inc. - COM (HUMA) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60,715,449 shares
.
Largest 10 shareholders include BlackRock, Inc. (8,225,144 shares), VANGUARD GROUP INC (6,599,646 shares), STATE STREET CORP (4,265,967 shares), HEIGHTS CAPITAL MANAGEMENT, INC (4,025,000 shares), Woodline Partners LP (3,950,000 shares), RA CAPITAL MANAGEMENT, L.P. (3,312,356 shares), CITADEL ADVISORS LLC (2,911,901 shares), GEODE CAPITAL MANAGEMENT, LLC (2,210,366 shares), TORONTO DOMINION BANK (2,131,390 shares), and Monashee Investment Management LLC (2,000,000 shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.